Autolus Therapeutics plc Initial Statement of Beneficial Ownership

Autolus Therapeutics plc executive Patrick Paul McIlvenny, SVP Finance, reports his initial equity holdings.

Rhea-AI Filing Summary

Autolus Therapeutics plc executive Patrick Paul McIlvenny, SVP Finance, reports his initial equity holdings. He holds share options over 150,000 American Depositary Shares with a $1.49 exercise price expiring on October 8, 2035, vesting 25% on October 8, 2026 and monthly thereafter. He also holds options over 148,000 ADS at $1.62 expiring on March 4, 2036, vesting 25% on March 4, 2027 and then in 36 monthly installments. In addition, he has 33,000 restricted share units that vest in four equal annual installments starting on March 4, 2027, each RSU representing one ADS.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider McIlvenny Patrick Paul

Role SVP Finance

Type	Security	Shares	Price	Value
holding	Share Option (right to buy)	--	--	--
holding	Share Option (right to buy)	--	--	--
holding	Restricted Share Units	--	--	--

Holdings After Transaction: Share Option (right to buy) — 298,000 contracts (Direct); Restricted Share Units — 33,000 contracts (Direct)

Footnotes (4)

1. F1. This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.
2. F2. This option vests 25% on March 4, 2027 and the remainder vests in 36 equal monthly installments thereafter.
3. F3. The RSUs vest in four equal annual installments commencing on March 4, 2027.
4. F4. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:55 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McIlvenny Patrick Paul

(Last) (First) (Middle)

C/O AUTOLUS THERAPEUTICS PLC

THE MEDIAWORKS, 191 WOOD LN, WHITE CITY

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP Finance

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	(1)	10/08/2035	American Depositary Shares	150,000	$1.49	D
Share Option (right to buy)	(2)	03/04/2036	American Depositary Shares	148,000	$1.62	D
Restricted Share Units	(3)	(3)	American Depositary Shares	33,000	(4)	D

Explanation of Responses:

1. This option vests 25% on October 8, 2026 and the remainder vests in 36 equal monthly installments thereafter.

2. This option vests 25% on March 4, 2027 and the remainder vests in 36 equal monthly installments thereafter.

3. The RSUs vest in four equal annual installments commencing on March 4, 2027.

4. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

	/s/ Patrick McIlvenny	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)